Urinary composition during decongestive treatment in heart failure with reduced ejection fraction

Circulation: Heart Failure

Volumn 7, Issue 5, 2014, Pages 766-772

  Verbrugge, Frederik H ^a,b   Nijst, Petra ^a,b   Dupont, Matthias ^a   Penders, Joris ^a,b   Tang, W H Wilson ^c   Mullens, Wilfried ^a,b  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Sodium; Systolic heart failure; Urea; Urine

Indexed keywords

ACETAZOLAMIDE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BUMETANIDE; CHLORIDE; CHLORTALIDONE; SODIUM; SPIRONOLACTONE; VASODILATOR AGENT; BIOLOGICAL MARKER; DIURETIC AGENT;

AGED; ARTICLE; CHLORIDE URINE LEVEL; CREATININE CLEARANCE; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SODIUM EXCRETION; SODIUM URINE LEVEL; URINALYSIS; URINE VOLUME; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECTS; ECHOGRAPHY; HEART STROKE VOLUME; HEART VENTRICLE; INTRAVENOUS DRUG ADMINISTRATION; MICTURITION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; URINE;

ADMINISTRATION, ORAL; AGED; BIOLOGICAL MARKERS; BUMETANIDE; CHLORIDES; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; INJECTIONS, INTRAVENOUS; MALE; SODIUM; SPIRONOLACTONE; STROKE VOLUME; TREATMENT OUTCOME; URINALYSIS; URINATION; VASODILATOR AGENTS;

EID: 84908359942     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001377     Document Type: Article

References (17)

1. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP. Characteristics and outcomes of patients hospitalized for heart failure in the united states: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (adhere). Am Heart J. 2005;149:209-216.
2. Fonarow GC, Corday E. Overview of acutely decompensated congestive heart failure (ADHF): a report from the adhere registry. Heart Fail Rev. 2004;9:179-185.
3. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675-683.
4. Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010;122: 265-272.
5. Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail. 2012;5:54-62.
6. Hasselblad V.,Gattis Stough W.,Shah M.R.,Lokhnygina Y,O'Connor C.M.,Califf R.M.Adams Jr. K.F, Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE trial,Eur J Heart Fail,2007,9,1064-1069.
7. Hasselblad V, Gattis Stough W, Shah MR, Lokhnygina Y, O'Connor CM, Califf RM, Adams KF Jr. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007;9:1064-1069. 7. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN. Hfsa 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16:e1-194.
8. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803-869.
9. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 accf/aha guideline for the management of heart failure: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 2013;128: e240-e327.
10. Verbrugge FH, Grieten L, Mullens W. New insights into combinational drug therapy to manage congestion in heart failure. Curr Heart Fail Rep. 2014;11:1-9.
11. Verbrugge FH, Dupont M, Steels P, Grieten L, Swennen Q, Tang WH, Mullens W. The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'. Eur J Heart Fail. 2014;16:133-142.
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
13. Wilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW, Friedman PA, Souney PF. Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med. 1983;102:450-458.
14. Wilcox CS, Guzman NJ, Mitch WE, Kelly RA, Maroni BJ, Souney PF, Rayment CM, Braun L, Colucci R, Loon NR. Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril. Kidney Int. 1987;31:135-141.
15. Kim GH. Long-term adaptation of renal ion transporters to chronic diuretic treatment. Am J Nephrol. 2004;24:595-605.
16. Krämer BK, Schweda F, Kammerl M, Riegger GA. Diuretic therapy and diuretic resistance in cardiac failure. Nephrol Dial Transplant. 1999;14(suppl 4):39-42.
17. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation. 1999;100:1311-1315.